Blood Irradiation Market Size, Share | Industry Trends 2022, 2028
The blood irradiation market is projected to reach US$ 104.37 million by 2028 from US$ 65.15 million in 2021; it is expected to grow at a CAGR of 7.0% from 2022 to 2028.
The rising prevalence of communicable and noncommunicable disorders and increasing research and development drive the market growth. However, the high cost of blood irradiation restricts the market growth.
Blood irradiation is achieved by exposing the blood to at least 25 Gy (2500 cGy) of radiation in the center of the vessel, preventing the replication and engraftment of immunologically competent donor T leukocytes to the recipient. GvHD caused by transplants from donors is almost always fatal, so patients at risk should receive irradiated blood products as time and resources allow. Clinical indications, including acute leukemia, lymphoma, solid tumors receiving intensive chemotherapy or radiation therapy, exchange transfusions, organ transplant recipients, and preterm infants, require blood irradiation therapy. Patients affected by human immunodeficiency virus/acquired immunodeficiency syndrome do not require blood product irradiation as they have not been reported to be susceptible to post-transfusion graft-to-host disease.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Blood Irradiation Market: Strategic Insights
Market Size Value in US$ 65.15 Million in 2021 Market Size Value by US$ 104.37 Million by 2028 Growth rate CAGR of 7.0% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Blood Irradiation Market: Strategic Insights
| Market Size Value in | US$ 65.15 Million in 2021 |
| Market Size Value by | US$ 104.37 Million by 2028 |
| Growth rate | CAGR of 7.0% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Increase in Prevalence of Communicable and Noncommunicable Diseases Drives Market Growth
There is an increase in the number of incidence of communicable and noncommunicable diseases, including cancer, cardiovascular disorders, chronic renal disease, and stroke, owing to a large population across the world susceptible to such conditions. According to World Health Organization (WHO), cardiovascular disorders are the leading cause of death globally, and ~17.9 million deaths are reported yearly. Additionally, the rising prevalence of communicable diseases, such as Hepatitis, influenza, Human Immunodeficiency Virus (HIV), and acquired immunodeficiency syndrome (AIDS), are driving the growth of the blood irradiation market. According to WHO, 325 million people were infected with the hepatitis B virus in 2020, and 900,000 people die from hepatitis B virus infection every year. Moreover, a large geriatric population across the world is contributing to the prevalence of noncommunicable diseases, such as cardiovascular disorders, renal disorders, and strokes. According to WHO, the population of people aged 60 years and above was 1 billion in 2019 and is expected to increase to 1.4 billion by 2030 and 2.1 billion by 2050. The elderly population is susceptible to noncommunicable disease conditions owing to various factors such as poor nutrition, lack of physical activity, excessive use of tobacco, and consumption of alcohol.
Additionally, surging blood transfusion owing to an increase in surgical procedures, accidents, trauma cases, and disorders, along with the rising prevalence of bloodstream infections, supports the market growth. Bloodstream infections, underlying conditions, and invasive procedures are common among the geriatric population. Bloodstream infections are the major cause of illness and death among large populations. According to the National Library of Medicine, ~28,000 bloodstream infections occur across the world annually. Moreover, rising awareness about bloodstream infections and increasing immune responses to transfused blood can cause complications as increasing use of irradiated blood in cancer treatment strengthens the immune system and improves overall health of patients, which is driving the growth of the blood irradiation market.
Thus, the increase in the prevalence of communicable and noncommunicable disorders, rise in blood transfusion, surge in bloodstream infections, and increase in immune responses are driving the growth of the blood irradiation market.
Type-Based Insights
The blood irradiation market, based on type, is segmented into intravenous laser blood irradiation , transcutaneous laser blood irradiation,and extracorporeal blood irradiation. In 2021, the intravenous laser blood irradiation segment accounted for the largest market share. However, the extracorporeal laser blood irradiation segment is expected to register the highest CAGR of 7.8% during the forecast period.
End User-Based Insights
Based on end user, the blood irradiation market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospitals segment held the largest market share in 2021. However, the blood banks segment is estimated to register the highest CAGR of 7.7% in the market during the forecast period.
Blood Irradiation Market Report Scope
Indication-Based Insights
By indication, the blood irradiation market is segmented into acute leukemia, solid tumors, pelvic tumors, lymphoma, and others. The acute leukemia segment held the largest market share in 2021. However, the lymphoma segment is estimated to register the highest CAGR of 8.8% in the market during the forecast period.
Companies operating in the blood irradiation market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market. For instance, in June 2021, Rad Source Technologies, a commercial X-ray radiation products supplier in the US, designed a product to replace self-shielded gamma irradiators and introduced its newly redesigned RS 3400 Blood Irradiator at MEDLAB Middle East 2021.
Blood Irradiation Market – by Geography
Geographically, the blood irradiation market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Typenex Medical, LLC; Hitachi Medical Systems; Rad Source Technologies; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Actemium; and Best Theratronics Ltd. are among the market participants included in the research study.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Indication, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global blood irradiation market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. In North America, the U.S. held the largest market share for blood irradiation market. The US is estimated to hold the largest share in the blood irradiation market during the forecast period. Increase in R&D activities along with surge in autoimmune disorders and organ transplants are the contributing factors for the regional growth. Additionally, increase in communicable and non-communicable diseases is the key factor responsible for the Asia-Pacific regional growth for blood irradiation accounting fastest growth of the region during the coming years.
Typenex Medical, LLC; Hitachi Medical Systems; Rad Source Technologies; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Actemium; Best Theratronics Ltd. are among the leading companies operating in the global blood irradiation market
The acute leukemia segment dominated the global blood irradiation market and accounted for the largest revenue of 26.93 Mn in 2021.
Blood irradiation is the process in which blood is exposed to low level of radiation which deactivates the T lymphocytes and inhibits the immune response for the prevention of rare graft-versus-host disease (GVHD). This therapy is also used for the treatment of various disorders such as autoimmune disorders, cancer, neuropathies and many more.
Increase in communicable and non-communicable diseases, rise in healthcare expenditure, and government initiatives are the most significant factors responsible for the overall market growth.
Based on type, intravenous laser blood irradiation took the forefront leaders in the worldwide market by accounting largest share in 2021 and is expected to continue to do so till the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Blood Irradiation Market – By Type
1.3.2 Global Blood Irradiation Market – By Indication
1.3.3 Global Blood Irradiation Market – By End User
1.3.4 Global Blood Irradiation Market – By Geography
2. Blood Irradiation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Blood Irradiation Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Blood Irradiation Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Communicable and Noncommunicable Diseases
5.1.2 Rise in Healthcare Expenditure and Government Initiatives
5.2 Market Restraints
5.2.1 Stringent Regulatory Policies, High Cost, and Challenges with Blood Component Irradiation
5.3 Market Opportunities
5.3.1 Increasing Immunocompromised Population and Rising Incidences of Leukemia And Lymphoma
5.4 Future Trends
5.4.1 Technological Advancements And Product Launches
5.5 Impact Analysis
6. Blood Irradiation Market– Global Analysis
6.1 Global Blood Irradiation Market Revenue Forecasts and Analysis
6.1.1 Overview
6.1.2 Global Blood Irradiation Market, and Forecast to 2028 (Units)
6.1.3 Global Blood Irradiation Market, By Geography - Forecasts and Analysis
6.1.4 Global Blood Irradiation Market – Market Potential Analysis, By Region
6.2 Company Analysis
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance Of Key Players
6.2.5 Hitachi Medical Systems
6.2.6 Best Theratronics
7. Blood Irradiation Market Analysis – By Type
7.1 Overview
7.2 Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
7.3 Intravenous Laser Blood Radiation
7.3.1 Overview
7.3.2 Intravenous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Transcutaneous Laser Blood Radiation
7.4.1 Overview
7.4.2 Transcutaneous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Extracorporeal Blood Radiation
7.5.1 Overview
7.5.2 Extracorporeal Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8. Blood Irradiation Market –By End User
8.1 Overview
8.2 Blood Irradiation Market, by End User, 2021 and 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Blood Banks
8.4.1 Overview
8.4.2 Blood Banks: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Diagnostic Centers
8.5.1 Overview
8.5.2 Diagnostic Centers: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Research Institutes
8.6.1 Overview
8.6.2 Research Institutes: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9. Blood Irradiation Market –By Indication
9.1 Overview
9.2 Blood Irradiation Market, by Indication, 2021 and 2028 (%)
9.3 Acute Leukemia
9.3.1 Overview
9.3.2 Acute Leukemia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Solid Tumors
9.4.1 Overview
9.4.2 Solid Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pelvic Tumors
9.5.1 Overview
9.5.2 Pelvic Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Lymphoma
9.6.1 Overview
9.6.2 Lymphoma: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10. Global Blood Irradiation Market – Geographic Analysis
10.1 North America: Blood Irradiation Market
10.1.1 Overview
10.1.2 North America: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.4 North America: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.5 North America: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.6 North America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.6.1.4 US: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.6.1.5 US: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.6.2 Canada: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.6.2.4 Canada: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.6.2.5 Canada: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.1.6.3 Mexico: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.1.6.3.4 Mexico: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.1.6.3.5 Mexico: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.2 Europe: Blood Irradiation Market
10.2.1 Overview
10.2.2 Europe: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.2.4 Europe: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.2.5 Europe: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.2.6 Europe: Blood Irradiation Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.2.6.1.4 Germany: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.2.6.1.5 Germany: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.2.6.2 UK: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 UK: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 UK: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.2.6.2.4 UK: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.2.6.2.5 UK: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.2.6.3 France: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.2.6.3.4 France: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.2.6.3.5 France: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.2.6.4 Italy: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.2.6.4.4 Italy: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.2.6.4.5 Italy: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.2.6.5 Spain: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.2.6.5.4 Spain: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.2.6.5.5 Spain: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.2.6.6 Rest of Europe: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.3 Asia Pacific: Blood Irradiation Market
10.3.1 Overview
10.3.2 Asia Pacific: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.3.4 Asia Pacific: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.3.6 Asia Pacific: Blood Irradiation Market, by Country, 2021 & 2028 (%)
10.3.6.1 China Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 China: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.3.6.1.4 China: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.3.6.1.5 China: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.3.6.2 Japan Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 Japan: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.3.6.2.5 Japan: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.3.6.3 India Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.3.6.3.4 India: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.3.6.3.5 India: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.3.6.4 South Korea Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 South Korea: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.3.6.4.4 South Korea: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.3.6.4.5 South Korea: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.3.6.5 Australia Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 Australia: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.3.6.5.4 Australia: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.3.6.5.5 Australia: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific Blood Irradiation Market Revenue and Forecasts to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.4 Middle East & Africa Blood Irradiation Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa: Blood Irradiation Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 Middle East & Africa: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.4.4 Middle East & Africa Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
10.4.5 Middle East & Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
10.4.6 Middle East & Africa: Blood Irradiation Market, by Country, 2021 & 2028 (%)
10.4.6.1 Saudi Arabia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 Saudi Arabia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Saudi Arabia: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.4.6.1.4 Saudi Arabia Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.5 Saudi Arabia Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2 UAE: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 UAE: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 UAE: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.4.6.2.4 UAE Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.5 UAE Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3 South Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 South Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 South Africa: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.4.6.3.4 South Africa Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.5 South Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4 Rest of Middle East & Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of Middle East & Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of Middle East & Africa: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.4.6.4.4 Rest of Middle East & Africa: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.4.6.4.5 Rest of Middle East & Africa: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.5 South and Central America Blood Irradiation Market Revenue and Forecasts To 2028
10.5.1 Overview
10.5.2 South and Central America: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.5.4 South and Central America: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.5.5 South and Central America: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.5.6 South and Central America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.5.6.1.4 Brazil: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.5.6.1.5 Brazil: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.5.6.2 Argentina: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.5.6.2.4 Argentina: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.5.6.2.5 Argentina: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South and Central America: Blood Irradiation Market, by Type, 2019–2028 (US$ Million)
10.5.6.3.4 Rest of South and Central America: Blood Irradiation Market, by End-Users, 2019–2028 (US$ Million)
10.5.6.3.5 Rest of South and Central America: Blood Irradiation Market, by Indication, 2019–2028 (US$ Million)
11. Impact of COVID-19 Pandemic on Global Blood Irradiation Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Blood Irradiation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Blood Irradiation Market, 2021-2028
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Hitachi, Ltd.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Best Theratronics Ltd.,
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Rad Source Technologies
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Gilardoni S.p.A.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Gamma-Service Medical GmbH
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Typenex Medical
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Actemium
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Global Blood Irradiation Market– Volume and Forecast to 2028 (Units)
Table 2. North America Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 8. Canada Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 11. Mexico Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Mexico Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 14. Europe Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Europe: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 16. Europe Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 17. Germany Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Germany: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 19. Germany Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 20. UK Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. UK: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 22. UK Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 23. France Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. France: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 25. France Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 26. Italy Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 27. Italy: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 28. Italy Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 29. Spain Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 30. Spain Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Europe Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Europe: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Europe Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 34. Asia Pacific Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 35. Asia Pacific: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 36. Asia Pacific Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 37. China Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. China Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 39. China Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 40. Japan Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 41. Japan Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 42. Japan Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 43. India Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 44. India Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 45. India Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 46. South Korea Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 47. South Korea Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 48. South Korea Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 49. Australia Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 50. Australia Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 52. Rest of Asia Pacific Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of Asia Pacific Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Asia Pacific Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 55. Middle East & Africa Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 56. Middle East & Africa Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 57. Middle East & Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 58. Saudi Arabia Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 59. Saudi Arabia Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 60. Saudi Arabia Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 61. UAE Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 62. UAE Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 63. UAE Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 64. South Africa Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 65. South Africa Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 66. South Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Middle East & Africa Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Middle East & Africa Blood Irradiation Market, by End-Users– Revenue and Forecast to 2028 (US$ Million)
Table 69. Rest of Middle East & Africa Blood Irradiation Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America: Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 71. South and Central America: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 72. South and Central America: Blood Irradiation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil: Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 74. Brazil: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 75. Brazil: Blood Irradiation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 76. Argentina: Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 77. Argentina: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 78. Argentina: Blood Irradiation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 79. Rest of South and Central America: Blood Irradiation Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 80. Rest of South and Central America: Blood Irradiation Market, by End-Users – Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South and Central America: Blood Irradiation Market, by Indication– Revenue and Forecast to 2028 (US$ Million)
Table 82. Recent Inorganic Growth Strategies in the Blood Irradiation Market
Table 83. Recent Organic Growth Strategies in the Blood Irradiation Market
Table 84. Glossary of Terms, Blood Irradiation Market
LIST OF FIGURES
Figure 1. Blood Irradiation Market Segmentation
Figure 2. Blood Irradiation Market Segmentation, By Region
Figure 3. Global Blood Irradiation Market Overview
Figure 4. Intravenous Laser Blood Irradiation Segment Held Largest Share of Type Segment in Blood Irradiation Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Blood Irradiation Market, by Geography (US$ Million)
Figure 7. Global Blood Irradiation Market- Leading Country Markets (US$ Million)
Figure 8. Global Blood Irradiation Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Blood Irradiation Market Impact Analysis of Drivers and Restraints
Figure 16. Global Blood Irradiation Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 17. Global Blood Irradiation Market – By Geography Forecasts and Analysis – 2021- 2028
Figure 18. Global Blood Irradiation Market – Market Potential Analysis, By Region
Figure 19. Market Positioning of Key Players In Global Blood Irradiation Market
Figure 20. Global Blood Irradiation Market – Comparative Company Analysis
Figure 21. Global Blood Irradiation Market – Growth Strategy Analysis
Figure 22. Blood Irradiation Market Revenue Share, by Type (2021 and 2028)
Figure 23. Intravenous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Transcutaneous Laser Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Extracorporeal Blood Radiation: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Blood Irradiation Market, by End User, 2021 and 2028 (%)
Figure 27. Hospitals: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Blood Banks: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Diagnostic Centers: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Research Institutes: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Blood Irradiation Market, by Indication, 2021 and 2028 (%)
Figure 32. Acute Leukemia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Solid Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Pelvic Tumors: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Lymphoma: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 36. Others: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America: Blood Irradiation Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 38. North America Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. North America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
Figure 40. US: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Canada: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Mexico: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Europe: Blood Irradiation Market, by Key Country – Revenue (2021) (US$ Million)
Figure 44. Europe Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe: Blood Irradiation Market, by Country, 2021 & 2028 (%)
Figure 46. Germany: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. UK: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. France: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Italy: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Spain: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Rest of Europe: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Asia Pacific: Blood Irradiation Market, by Key Country – Revenue (2021) (US$ Million)
Figure 53. Asia Pacific Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
Figure 54. Asia Pacific: Blood Irradiation Market, by Country, 2021 & 2028 (%)
Figure 55. China: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Japan: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. India: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. South Korea: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Australia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Rest of Asia Pacific: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Middle East & Africa: Blood Irradiation Market, by Key Country – Revenue (2021) (US$ Million)
Figure 62. Middle East & Africa Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. Middle East & Africa: Blood Irradiation Market, by Country, 2021 & 2028 (%)
Figure 64. Saudi Arabia: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. UAE: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. South Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 67. Rest of Middle East & Africa: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. South and Central America: Blood Irradiation Market, by Key Country – Revenue (2021) (US$ Million)
Figure 69. South and Central America Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
Figure 70. South and Central America: Blood Irradiation Market, by Country, 2021 & 2028 (%)
Figure 71. Brazil: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 72. Argentina: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 73. Rest of South and Central America: Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
Figure 74. Impact Of COVID-19 Pandemic in North American Country Markets
Figure 75. Impact of COVID-19 Pandemic in European Country Markets
Figure 76. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 77. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 78. Impact of COVID-19 Pandemic in South and Central American Countries
Figure 79. Growth Strategies in the Blood Irradiation Market, 2021-2028
The List of Companies - Blood Irradiation Market
- Typenex Medical, LLC
- Hitachi Medical Systems
- Rad Source Technologies
- Gilardoni S.p.A.
- Gamma-Service Medical GmbH
- Actemium
- Best Theratronics Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For